Skip to content
Salarius
Primary Menu
About Us
Overview
Leadership Team
Board of Directors
Our Programs
Targeted Protein Inhibition
Targeted Protein Degradation
Pipeline
Publications Review
Clinical Trials
News & Events
Press Releases
Events
In the News
Investors
Overview
Corporate Governance
Corporate Governance
Committee Composition
Press Releases
In The News
Financial Reports
Annual Reports
Quarterly & Other Reports
Tax Documents
SEC Filings
Events & Presentations
Investor Resources
Investor FAQs
Information Request
E-mail Alerts
Contact IR
Stock Information
Stock Quote
Stock Chart
Historical Price Lookup
Analyst Coverage
Contact Us
Search
Search for:
News & Events
Back
Salarius, Aspire Capital announce a $10.9M stock purchase agreement
